MatriSys Bioscience Revenue and Competitors
Estimated Revenue & Valuation
- MatriSys Bioscience's estimated annual revenue is currently $1.1M per year.
- MatriSys Bioscience's estimated revenue per employee is $155,000
Employee Data
- MatriSys Bioscience has 7 Employees.
- MatriSys Bioscience grew their employee count by 17% last year.
MatriSys Bioscience's People
Name | Title | Email/Phone |
---|
MatriSys Bioscience Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is MatriSys Bioscience?
MatriSys Bio is a clinical stage Specialty Biopharmaceutical Company focused on the $142 Billion WW dermatology and skin care market. We are developing therapies for the top 5 dermatology & skin care conditions - Atopic Dermatitis, Rosacea, Psoriasis, Acne, and Skin Infections, which have a huge impact on quality of life. More than 230 million patients suffer from these 5 skin diseases, which represent a $12.9 Billion Rx market and a $121 Billion skin care market. MatriSys Bio's scientific approach is to rebalance the natural skin microbiome by application of microbial therapies -“Good Bugs†that selectively target skin pathogens -“Bad Bugsâ€. Our lead microbiome Phase I/II clinical program addresses the Atopic Dermatitis (“ADâ€) market with 15 M US patients (132 M worldwide), is NIH funded, and IP protected with an exclusive license from UCSD. Our “Good Bugâ€, S. hominis, is highly potent against the “Bad Bugâ€, Staph. aureus, which has long been associated with AD. S. hominis does not affect other “Good Bugs†leading to the natural rebalance of the skin microbiome.
keywords:N/AN/A
Total Funding
7
Number of Employees
$1.1M
Revenue (est)
17%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.5M | 7 | -12% | N/A |
#2 | $1.1M | 7 | -42% | N/A |
#3 | $0.6M | 7 | N/A | N/A |
#4 | $1.1M | 7 | -30% | N/A |
#5 | $0.6M | 7 | 17% | N/A |